Notify me when THORNBURG INVESTMENT MANAGEMENT INC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 176 | $7,925,044,389 | +$455,038,376 | -$330,698,302 | +$124,340,074 | C, T, AVGO, MRK, CME | 13F-HR | 13 Feb 2026, 10:47 |
| Q3 2025 | 176 | $7,665,789,789 | +$330,686,769 | -$942,261,107 | -$611,574,338 | C, T, AVGO, CME, MRK | 13F-HR | 12 Nov 2025, 06:10 |
| Q2 2025 | 177 | $7,774,582,487 | +$56,241,621 | $0 | +$56,241,621 | T, AVGO, C, MRK, CME | 13F-HR | 12 Aug 2025, 20:03 |
| Q1 2025 | 182 | $96,319,545 | $0 | $0 | $0 | CCZ | 13F-HR | 07 May 2025, 18:53 |
| Q4 2024 | 188 | $7,567,431,722 | +$258,154,216 | -$489,162,954 | -$231,008,738 | AVGO, T, C, CME, PFE | 13F-HR | 13 Feb 2025, 18:04 |
| Q3 2024 | 192 | $7,684,252,782 | +$1,084,270,940 | -$364,421,301 | +$719,849,639 | AVGO, T, C, CME, PFE | 13F-HR | 08 Nov 2024, 17:55 |
| Q2 2024 | 189 | $7,106,485,525 | +$516,598,075 | -$619,451,074 | -$102,852,999 | AVGO, T, C, PFE, CME | 13F-HR | 07 Aug 2024, 18:37 |
| Q1 2024 | 187 | $7,168,481,046 | +$403,741,480 | -$965,514,641 | -$561,773,161 | AVGO, C, T, JPM, CME | 13F-HR | 13 May 2024, 16:58 |
| Q4 2023 | 196 | $6,931,058,810 | +$647,237,360 | -$469,626,878 | +$177,610,482 | AVGO, C, CME, T, JPM | 13F-HR | 08 Feb 2024, 11:15 |
| Q3 2023 | 196 | $6,083,624,000 | +$492,224,521 | -$444,529,489 | +$47,695,032 | AVGO, CME, PFE, JPM, C | 13F-HR | 13 Nov 2023, 10:38 |
| Q2 2023 | 184 | $6,171,217,000 | +$432,733,759 | -$597,304,576 | -$164,570,817 | AVGO, CME, PFE, JPM, QCOM | 13F-HR | 08 Aug 2023, 16:04 |
| Q1 2023 | 185 | $6,052,274,000 | +$327,146,595 | -$467,920,535 | -$140,773,940 | AVGO, CME, PFE, JPM, QCOM | 13F-HR | 09 May 2023, 13:01 |
| Q4 2022 | 201 | $5,914,564,000 | +$254,267,472 | -$595,741,877 | -$341,474,405 | PFE, AVGO, CME, JPM, RF | 13F-HR | 07 Feb 2023, 18:23 |
| Q3 2022 | 200 | $5,645,891,000 | +$409,912,777 | -$691,458,185 | -$281,545,408 | CME, PFE, AVGO, RF, QCOM | 13F-HR | 14 Nov 2022, 17:59 |
| Q2 2022 | 201 | $6,529,757,000 | +$668,812,111 | -$608,413,386 | +$60,398,725 | CME, ABBV, AVGO, PFE, QCOM | 13F-HR | 05 Aug 2022, 14:04 |
| Q1 2022 | 196 | $7,631,993,000 | +$411,144,830 | -$766,131,068 | -$354,986,238 | CME, AVGO, ABBV, PFE, QCOM | 13F-HR | 11 May 2022, 18:23 |
| Q4 2021 | 208 | $8,528,684,000 | +$803,405,033 | -$1,041,954,394 | -$238,549,361 | AVGO, CME, ABBV, QCOM, PFE | 13F-HR | 10 Feb 2022, 17:22 |
| Q3 2021 | 209 | $8,145,877,000 | +$706,945,033 | -$983,981,625 | -$277,036,592 | CME, AVGO, ABBV, JPM, HD | 13F-HR | 09 Nov 2021, 18:23 |
| Q2 2021 | 1 | $9,008,000 | $0 | $0 | $0 | GTES | New Holdings | 12 Oct 2021, 16:08 |
| Q2 2021 | 206 | $8,696,004,000 | +$675,901,420 | -$858,562,726 | -$182,661,306 | CME, JPM, ABBV, AVGO, CIM | 13F-HR | 10 Aug 2021, 18:55 |
| Q1 2021 | 207 | $8,615,564,000 | +$719,487,688 | -$1,091,544,725 | -$372,057,037 | JPM, CME, ABBV, AVGO, BABA | 13F-HR | 14 May 2021, 15:38 |
| Q4 2020 | 227 | $8,426,616,000 | +$1,709,631,225 | -$2,117,335,966 | -$407,704,741 | CME, JPM, AVGO, ABBV, BABA | 13F-HR | 09 Feb 2021, 13:51 |
| Q3 2020 | 164 | $7,564,599,000 | +$342,752,039 | -$957,007,370 | -$614,255,331 | BABA, JPM, CME, ABBV, HD | 13F-HR | 05 Nov 2020, 13:06 |
| Q2 2020 | 159 | $7,787,930,000 | +$799,763,517 | -$1,386,767,200 | -$587,003,683 | ABBV, BABA, JPM, CME, HD | 13F-HR | 07 Aug 2020, 14:17 |
| Q1 2020 | 163 | $6,992,768,000 | +$696,559,450 | -$1,443,755,557 | -$747,196,107 | BABA, CME, JPM, WBA, RDSA | 13F-HR | 13 May 2020, 13:43 |
| Q4 2019 | 171 | $10,397,123,000 | +$499,879,881 | -$1,403,194,633 | -$903,314,752 | CME, JPM, RDSA, BABA, QCOM | 13F-HR | 07 Feb 2020, 18:05 |
| Q3 2019 | 170 | $10,368,607,000 | +$576,087,498 | -$750,826,985 | -$174,739,487 | CME, JPM, RDSA, BABA, HD | 13F-HR | 12 Nov 2019, 13:20 |
| Q2 2019 | 170 | $10,421,323,000 | +$722,616,769 | -$1,019,963,365 | -$297,346,596 | CME, RDSA, JPM, BABA, QCOM | 13F-HR | 06 Aug 2019, 12:04 |
| Q1 2019 | 175 | $10,336,235,000 | +$639,962,122 | -$1,508,223,671 | -$868,261,549 | RDSA, CME, JPM, BABA, WBA | 13F-HR | 07 May 2019, 16:00 |
| Q4 2018 | 171 | $10,219,371,000 | +$766,231,563 | -$900,510,999 | -$134,279,436 | CME, RDSA, JPM, WBA, QCOM | 13F-HR | 06 Feb 2019, 16:00 |
| Q3 2018 | 161 | $11,985,338,000 | +$811,080,783 | -$2,290,526,964 | -$1,479,446,181 | RDSA, CME, JPM, WBA, QCOM | 13F-HR | 02 Nov 2018, 10:58 |
| Q2 2018 | 227 | $13,157,384,000 | +$1,063,499,730 | -$1,467,069,532 | -$403,569,802 | RDSA, CME, JPM, WBA, HD | 13F-HR | 14 Aug 2018, 10:38 |
| Q1 2018 | 231 | $13,259,975,000 | +$1,274,073,454 | -$2,074,736,127 | -$800,662,673 | RDSA, CME, JPM, WBA, HD | 13F-HR | 07 May 2018, 10:43 |
| Q4 2017 | 243 | $14,381,867,000 | +$1,219,189,483 | -$1,271,018,215 | -$51,828,732 | JPM, CME, RDSA, HD, QCOM | 13F-HR | 14 Feb 2018, 10:17 |
| Q3 2017 | 243 | $14,002,536,000 | +$1,911,272,535 | -$1,483,846,124 | +$427,426,411 | JPM, CME, RDSA, HD, MRK | 13F-HR | 13 Nov 2017, 09:59 |
| Q2 2017 | 249 | $13,143,252,000 | +$1,750,798,193 | -$1,466,555,150 | +$284,243,043 | JPM, CME, RDSA, HD, MRK | 13F-HR | 14 Aug 2017, 10:22 |
| Q1 2017 | 265 | $12,305,694,000 | +$1,473,573,284 | -$2,826,028,190 | -$1,352,454,906 | JPM, CME, RDSA, HD, WBA | 13F-HR | 09 May 2017, 10:36 |
| Q4 2016 | 273 | $12,953,001,000 | +$1,388,446,880 | -$1,819,837,617 | -$431,390,737 | JPM, CME, RDSA, HD, WBA | 13F-HR | 10 Feb 2017, 13:48 |
| Q3 2016 | 254 | $13,130,401,000 | +$1,211,886,675 | -$1,693,903,580 | -$482,016,905 | JPM, CME, RDSA, AGN, HD | 13F-HR | 14 Nov 2016, 09:27 |
| Q2 2016 | 260 | $12,919,157,000 | +$1,353,163,605 | -$3,483,851,906 | -$2,130,688,301 | JPM, RDSA, CME, AGN, HD | 13F-HR | 12 Aug 2016, 12:05 |
| Q1 2016 | 264 | $14,997,571,000 | +$2,115,755,370 | -$2,968,388,869 | -$852,633,499 | JPM, CME, HD, T, C | 13F-HR | 12 May 2016, 10:58 |
| Q4 2015 | 292 | $15,743,179,000 | +$1,608,941,005 | -$2,041,403,962 | -$432,462,957 | CME, JPM, HD, T, RDSA | 13F-HR | 09 Feb 2016, 11:57 |
| Q3 2015 | 275 | $15,943,872,000 | +$3,203,396,673 | -$2,883,691,683 | +$319,704,990 | CME, JPM, HD, T, AGN | 13F-HR | 12 Nov 2015, 10:17 |
| Q2 2015 | 306 | $17,363,706,000 | +$3,605,173,772 | -$4,496,164,073 | -$890,990,301 | CME, JPM, RDSA, HD, LBTYK | 13F-HR | 12 Aug 2015, 09:25 |
| Q1 2015 | 306 | $17,971,360,000 | +$2,493,867,713 | -$4,574,030,989 | -$2,080,163,276 | JPM, CME, RDSA, NXPI, LBTYK | 13F-HR | 13 May 2015, 11:53 |
| Q4 2014 | 303 | $19,993,658,000 | +$2,741,795,713 | -$5,324,884,151 | -$2,583,088,438 | JPM, RDSA, LBTYK, BIDU, BABA | 13F-HR | 11 Feb 2015, 11:04 |
| Q3 2014 | 312 | $22,157,007,000 | +$2,498,784,614 | -$4,963,283,038 | -$2,464,498,424 | JPM, BIDU, B108PS, LBTYK, SLB | 13F-HR | 12 Nov 2014, 10:07 |
| Q2 2014 | 319 | $25,072,636,000 | +$4,348,841,100 | -$5,219,671,949 | -$870,830,849 | SLB, BIDU, TSM, JPM, ACN | Restatement | 11 Aug 2014, 14:35 |
| Q1 2014 | 292 | $25,403,775,000 | +$4,289,242,671 | -$4,045,812,809 | +$243,429,862 | SLB, BIDU, YUM, ACN, BBVA | 13F-HR | 14 May 2014, 16:41 |
| Q4 2013 | 284 | $26,203,978,000 | $0 | $0 | $0 | BIDU, SLB, YUM, YNDX, LBTYA | 13F-HR | 13 Feb 2014, 13:57 |